A Model to Evaluate the Immunogenicity Costs of Tumour Necrosis Factor-Alpha Inhibitors in Patients with Rheumatoid Arthritis
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1491
https://www.valueinhealthjournal.com/article/S1098-3015(13)03396-2/fulltext
Title :
A Model to Evaluate the Immunogenicity Costs of Tumour Necrosis Factor-Alpha Inhibitors in Patients with Rheumatoid Arthritis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03396-2&doi=10.1016/j.jval.2013.08.1491
First page :
A563
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1335